Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

By Carpini Jennifer  

Angiogenesis, Vol. 13, Iss. 1, 2010-03 ,pp. : 43-58

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

By Artini PG   Cristello F   Monti M   Cela V   Battaglia C   D'Ambrogio G   Genazzani AR  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 50-56

Informa Healthcare

Access to resources Recommend Favorite

Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients

By Parr Christian   Gan Chun   Watkins Gareth   Jiang Wen  

Angiogenesis, Vol. 9, Iss. 2, 2006-06 ,pp. : 73-81

Springer Publishing Company

Access to resources Recommend Favorite

The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor

By Tsuchiya Takehiko   Nakahama Ken-Ichi   Asakawa Yasuyuki   Maemura Toshimitu   Tanaka Masanobu   Takeda Satoru   Morita Mineto   Morita Ikuo  

Gynecological Endocrinology, Vol. 25, Iss. 2, 2009-02 ,pp. : 104-109

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response

By Manau Dolors  

Human Reproduction, Vol. 15, Iss. 6, 2000-06 ,pp. : 1295-1299

Oxford University Press

Access to resources Recommend Favorite